Form 4: CareDx Director Christine Cournoyer Reports Stock and Option Awards

Christine Cournoyer, a director at CareDx, Inc., reported the acquisition of restricted stock units and stock options.

Summary

• On June 14, 2024, Christine Cournoyer, a director of CareDx, Inc., reported the acquisition of 10,570 shares of common stock in the form of restricted stock units and 16,048 stock options.
• The restricted stock units vest in one installment on June 14, 2025.
• The stock options vest monthly, with 1/12th of the shares vesting on July 14, 2024, and the remainder vesting monthly thereafter through June 14, 2025.
• The exercise price of the stock options is $14.19.
• Following these transactions, Cournoyer directly owns 53,745 shares of common stock and 16,048 stock options.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock and option awards to a director. It doesn't inherently convey strong positive or negative sentiment, but rather provides factual information about insider transactions.

Positives

• The acquisition of stock and options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Stakeholder Impact

• Shareholders may be interested in the director's increased stake in the company.

Key Dates